Key result
Hindlimb arterial injection of indomethacin reduced the pressor response during skeletal muscle stretch in rats with simulated peripheral artery disease (12 vs 30 mmHg; P<0.01).
Why the study?
The cyclooxygenase pathway contributes to the exaggerated exercise pressor reflex in peripheral artery disease, but the specific mechanisms of this cyclooxygenase-mediated exaggeration are unknown.
Does indomethacin reduce the pressor response during skeletal muscle stretch in a rat model of simulated peripheral artery disease?
Does indomethacin reduce the pressor response during skeletal muscle stretch in a rat model of simulated peripheral artery disease?
Absolute Event Rate: 12% vs 30%
p-value: p=<0.01
The COX pathway sensitizes the mechanoreflex in a rat model of PAD via increased expression of COX metabolite receptors on sensory neurons, which may explain exaggerated blood pressure responses during exercise in PAD patients.
COX inhibition may blunt exaggerated exercise pressor reflex in PAD; leaves open precise metabolites or isoforms involved.
Mechanical and metabolic stimuli within contracting skeletal muscles reflexly increase sympathetic nervous system activity and blood pressure. That reflex, termed the exercise pressor reflex, is exaggerated in patients with peripheral artery disease (PAD) and in a rat PAD model with a chronically ligated femoral artery. The cyclooxygenase (COX) pathway contributes to the exaggerated pressor response during rhythmic skeletal muscle contractions in patients with PAD, but the specific mechanism(s) of the COX-mediated exaggeration are not known. In decerebrate, unanesthetized rats with a chronically ligated femoral artery (“ligated” rats), we hypothesized that hindlimb arterial injection of the COX inhibitor indomethacin would reduce the pressor response during 1-Hz dynamic hindlimb skeletal muscle stretch; a model of the activation of the mechanical component of the exercise pressor reflex (i.e., the mechanoreflex). In ligated rats ( n = 7), indomethacin reduced the pressor response during stretch (control: 30 ± 4; indomethacin: 12 ± 3 mmHg; P < 0.01), whereas there was no effect in rats with “freely perfused” femoral arteries ( n = 6, control: 18 ± 5; indomethacin: 17 ± 5 mmHg; P = 0.87). In ligated rats ( n = 4), systemic indomethacin injection had no effect on the pressor response during stretch. Femoral artery ligation had no effect on skeletal muscle COX protein expression or activity or concentration of the COX metabolite prostaglandin E 2 . Conversely, femoral artery ligation increased expression of the COX metabolite receptors endoperoxide 4 and thromboxane A 2 -R in dorsal root ganglia tissue. We conclude that, in ligated rats, the COX pathway sensitizes the peripheral endings of mechanoreflex afferents, which occurs principally as a result of increased expression of COX metabolite receptors. NEW & NOTEWORTHY We demonstrate that the mechanoreflex is sensitized by the cyclooxygenase (COX) pathway within hindlimb skeletal muscles in the rat chronic femoral artery ligation model of simulated peripheral artery disease (PAD). The mechanism of sensitization appears attributable to increased receptors for COX metabolites on sensory neurons and not increased concentration of COX metabolites. Our data may carry important clinical implications for patients with PAD who demonstrate exaggerated increases in blood pressure during exercise compared with healthy counterparts.
No takes yet. Share an insight, caveat, or question.
Butenas et al. (2019) studied peripheral artery disease (PAD) (n=17). Indomethacin vs. Control was evaluated on Pressor response during 1-Hz dynamic hindlimb skeletal muscle stretch (p=<0.01). Hindlimb arterial injection of indomethacin reduced the pressor response during skeletal muscle stretch in rats with simulated peripheral artery disease (12 vs 30 mmHg; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: